{"schema_version":"1","generated_at":"2026-11-03T06:31:10.162Z","data_as_of":null,"url":"https://www.findmykol.com/kol/oreofe-odejide","json_url":"https://www.findmykol.com/kol/oreofe-odejide/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"oreofe-odejide","name":"Oreofe Odejide","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Harvard University","institution_url":"https://www.findmykol.com/institution/harvard-university","city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1235398488","orcid":"0000-0002-8117-7224","openalex":"A5019564077"},"summary":"Oreofe Odejide is an Oncology physician affiliated with Harvard University. OpenAlex indexes 144 publications with 2,876 citations (h-index 25); ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":144,"cited_by_count":2876,"h_index":25,"latest_activity_year":2025,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06487247","title":"HEME Home Transfusion Program","phase":"NA","status":"RECRUITING","role":"Overall official","sponsor":"Dana-Farber Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT06487247","trial_url":"https://www.findmykol.com/trial/NCT06487247"},{"nct":"NCT05509439","title":"Home Transfusion for HEME","phase":"NA","status":"COMPLETED","role":"Overall official","sponsor":"Dana-Farber Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT05509439","trial_url":"https://www.findmykol.com/trial/NCT05509439"},{"nct":"NCT05080166","title":"UPLYFT For Lymphoma Survivors","phase":"NA","status":"COMPLETED","role":"Overall official","sponsor":"Dana-Farber Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT05080166","trial_url":"https://www.findmykol.com/trial/NCT05080166"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2023,"amount_usd":4110,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1235398488"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1235398488","source":"payments"},"prescribing":{"data_year":2024,"areas_total":3,"areas_shown":3,"areas":[{"area":"Anti-infectives","share_pct":40,"classes_total":1,"classes":[{"class":"Short-acting sulfonamides","setting":"prescribed","share_pct":40,"drugs":[{"name":"Sulfamethoxazole-Trimethoprim","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":32.5,"classes_total":1,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":32.5,"drugs":[{"name":"Calquence","share_pct":100}],"max_beneficiaries":null}]},{"area":"Dermatology","share_pct":27.5,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":27.5,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":2,"fiscal_years":{"first":2017,"last":2024},"rows_total":7,"shown":3,"withheld":4,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R37CA289639","title":"HEME-Hospice: An Intervention to improve Hospice Use for Patients with Hematologic Malignancies","fiscal_year":2024,"amount_usd":"731526","organization":"DANA-FARBER CANCER INST","source_url":"https://reporter.nih.gov/quickSearch/R37CA289639"},{"project":"K08CA218295","title":"Improving Hospice Use for Patients with Blood Cancers","fiscal_year":2022,"amount_usd":"127276","organization":"DANA-FARBER CANCER INST","source_url":"https://reporter.nih.gov/quickSearch/K08CA218295"},{"project":"K08CA218295","title":"Improving Hospice Use for Patients with Blood Cancers","fiscal_year":2021,"amount_usd":"169702","organization":"DANA-FARBER CANCER INST","source_url":"https://reporter.nih.gov/quickSearch/K08CA218295"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2025016006","status":"verified"},{"title":"Integrative epidemiology and immunotranscriptomics uncover a risk and potential mechanism for cutaneous lymphoma unmasking or progression with dupilumab therapy","year":2024,"journal":"Journal of Allergy and Clinical Immunology","source_url":"https://doi.org/10.1016/j.jaci.2024.10.028","status":"verified"},{"title":"Mental health disorders and survival among older patients with diffuse large B-cell lymphoma in the USA: a population-based study","year":2023,"journal":"The Lancet Haematology","source_url":"https://doi.org/10.1016/s2352-3026(23)00094-7","status":"verified"},{"title":"Early palliative care versus usual haematological care in multiple myeloma: retrospective cohort study","year":2023,"journal":"BMJ Supportive & Palliative Care","source_url":"https://doi.org/10.1136/spcare-2023-004524","status":"verified"},{"title":"A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma","year":2023,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2023020244","status":"verified"}],"source":"works"},"contact":{"address_1":"75 FRANCIS ST","city":"Boston","state":"MA","zip":"021156110","phone":"617-732-5775","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1235398488","source":"identity"},"similar":[{"name":"Thoralf Sundt","slug":"thoralf-sundt","institution":"Harvard University","specialty":"Thoracic Surgery (Cardiothoracic Vascular Surgery)","url":"https://www.findmykol.com/kol/thoralf-sundt","json_url":"https://www.findmykol.com/kol/thoralf-sundt/profile.json"},{"name":"Felipe Fregni","slug":"felipe-fregni","institution":"Harvard University","specialty":"Neurology","url":"https://www.findmykol.com/kol/felipe-fregni","json_url":"https://www.findmykol.com/kol/felipe-fregni/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Sarah Fortune","slug":"sarah-fortune","institution":"Harvard University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/sarah-fortune","json_url":"https://www.findmykol.com/kol/sarah-fortune/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"funding":4,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2018-11-15","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}